标题
Trial Watch
作者
关键词
-
出版物
OncoImmunology
Volume 1, Issue 4, Pages 493-506
出版商
Informa UK Limited
发表日期
2012-07-03
DOI
10.4161/onci.20459
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inflammasome Activators Induce Interleukin-1α Secretion via Distinct Pathways with Differential Requirement for the Protease Function of Caspase-1
- (2012) Olaf Groß et al. IMMUNITY
- Inflammasomes in carcinogenesis and anticancer immune responses
- (2012) Laurence Zitvogel et al. NATURE IMMUNOLOGY
- Denosumab in patients with cancer—a surgical strike against the osteoclast
- (2012) Janet E. Brown et al. Nature Reviews Clinical Oncology
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
- (2012) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
- (2012) Craig Leonardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Paraneoplastic Thrombocytosis in Ovarian Cancer
- (2012) Rebecca L. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial Watch: Monoclonal antibodies in cancer therapy
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- 20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose Matters
- (2011) Jan P. Deroose et al. ANNALS OF SURGICAL ONCOLOGY
- A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis
- (2011) Michael Yellin et al. ARTHRITIS AND RHEUMATISM
- SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans
- (2011) Aili L. Lazaar et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma
- (2011) Sally A. Hunsucker et al. BRITISH JOURNAL OF HAEMATOLOGY
- Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases
- (2011) J. P. Deroose et al. BRITISH JOURNAL OF SURGERY
- Prerequisites for the Antitumor Vaccine-Like Effect of Chemotherapy and Radiotherapy
- (2011) Dalil Hannani et al. CANCER JOURNAL
- Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
- (2011) S. R. Mattarollo et al. CANCER RESEARCH
- IL-18 Induces PD-1-Dependent Immunosuppression in Cancer
- (2011) M. Terme et al. CANCER RESEARCH
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
- (2011) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- The many faces of Th17 cells
- (2011) Anneli Peters et al. CURRENT OPINION IN IMMUNOLOGY
- Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
- (2011) K. Fizazi et al. EUROPEAN JOURNAL OF CANCER
- Functional Specialization of Interleukin-17 Family Members
- (2011) Yoichiro Iwakura et al. IMMUNITY
- Homeostatic defects in interleukin 18-deficient mice contribute to protection against the lethal effects of endotoxin
- (2011) Daniel M Andrews et al. IMMUNOLOGY AND CELL BIOLOGY
- Mini-review series: focus on chemokines
- (2011) Iain Comerford et al. IMMUNOLOGY AND CELL BIOLOGY
- Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer
- (2011) Lucia De Monte et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy
- (2011) Yuting Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
- (2011) Nicolas F Delahaye et al. NATURE MEDICINE
- Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
- (2011) Vinod P Balachandran et al. NATURE MEDICINE
- New targets for intervention in the treatment of postmenopausal osteoporosis
- (2011) E. Michael Lewiecki Nature Reviews Rheumatology
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- Does IL-17 suppress tumor growth?
- (2010) S. F. Ngiow et al. BLOOD
- Combination of temozolomide with immunocytokine F16–IL2 for the treatment of glioblastoma
- (2010) M Pedretti et al. BRITISH JOURNAL OF CANCER
- Signaling of interleukin-17 family cytokines in immunity and inflammation
- (2010) Seon Hee Chang et al. CELLULAR SIGNALLING
- Biology of interleukin-10
- (2010) Robert Sabat et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
- (2010) Manfred Johannsen et al. EUROPEAN JOURNAL OF CANCER
- Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
- (2010) Daniel Schramek et al. NATURE
- Molecular mechanisms of necroptosis: an ordered cellular explosion
- (2010) Peter Vandenabeele et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Bone morphogenetic proteins
- (2009) D. A. Towler BLOOD
- A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma
- (2009) Ahmad A. Tarhini et al. CANCER
- The High-Dose Aldesleukin (IL-2) “Select” Trial: A Trial Designed to Prospectively Validate Predictive Models of Response to High-Dose IL-2 Treatment in Patients With Metastatic Renal Cell Carcinoma
- (2009) Jessica M. Clement et al. Clinical Genitourinary Cancer
- Fontolizumab in moderate to severe Crohnʼs disease: A phase 2, randomized, double-blind, placebo-controlled, multiple-dose study
- (2009) Walter Reinisch et al. INFLAMMATORY BOWEL DISEASES
- Correlation of Decreased Survival and IL-18 in Bone Metastasis
- (2009) Masaki Okamoto et al. INTERNAL MEDICINE
- IL-18 Paradox in Pancreatic Carcinoma: Elevated Serum Levels of Free IL-18 are Correlated With Poor Survival
- (2009) Anna Carbone et al. JOURNAL OF IMMUNOTHERAPY
- Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC
- (2009) Helena Linardou et al. Nature Reviews Clinical Oncology
- Plerixafor
- (2009) John F. DiPersio et al. NATURE REVIEWS DRUG DISCOVERY
- An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
- (2009) Ivona Aksentijevich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modulation of CCR2 in rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled clinical trial
- (2008) Clarissa E. Vergunst et al. ARTHRITIS AND RHEUMATISM
- Hematopoietic cytokines
- (2008) D. Metcalf BLOOD
- IL-21 and TGF-β are required for differentiation of human TH17 cells
- (2008) Li Yang et al. NATURE
- A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions
- (2008) C. Grutter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started